Deutsche Tageszeitung - UK's King Charles III diagnosed with cancer: Buckingham Palace

UK's King Charles III diagnosed with cancer: Buckingham Palace


UK's King Charles III diagnosed with cancer: Buckingham Palace
UK's King Charles III diagnosed with cancer: Buckingham Palace / Photo: © AFP

King Charles III has been diagnosed with a form of cancer and has begun treatment, Buckingham Palace said on Monday, just a week after he was discharged from hospital for prostate surgery.

Change text size:

Following the announcement, the 75-year-old Charles's estranged son Prince Harry immediately made it known that he had spoken with the king about his diagnosis.

His younger son who now lives in California with his wife Meghan said he would travel to see his father in the UK over the coming days, a source close to Harry was quoted as saying by the PA news agency.

Charles, who became king upon the death of his mother, Queen Elizabeth II, on September 8, 2022, has generally enjoyed good health, barring injuries from polo and skiing.

But the palace said that during his recent hospital procedure for benign prostate enlargement "a separate issue of concern was noted".

"Subsequent diagnostic tests have identified a form of cancer," the palace said in a statement, adding that he had begun treatment.

The palace said the king "remains wholly positive" and "looks forward to returning to full public duty as soon as possible".

In the meantime he had been advised by doctors to postpone public duties although he would continue to "undertake state business and official paperwork as usual", it said.

- Avoid speculation -

The king won plaudits for being open about his benign prostate condition, with doctors saying many more members of the public had come forward with symptoms.

The palace added that Charles had chosen to share his cancer diagnosis "to prevent speculation and in the hope it may assist public understanding for all those around the world who are affected by cancer".

The diagnosis will prolong a frontline shortage of royals created by Charles's prostate procedure and the almost simultaneous hospitalisation of Catherine, Princess of Wales.

Catherine, 42, who is the wife of Charles's son and heir to the throne Prince William, underwent abdominal surgery at the same hospital that Charles was treated in.

She left last Monday on the same day as Charles following a stay of around of two weeks and may not return to public duties until late March.

Her husband William, 41, also stepped back temporarily from planned engagements to help care for their three children.

The pair's absence left Queen Camilla, Charles's 76-year-old wife, as the most visible face of the royal family.

William is expected to return to royal duties this week.

At the time of Catherine's operation, Kensington Palace stressed that her condition was not linked to cancer, without elaborating.

(M.Dorokhin--DTZ)

Featured

RCSI President Calls for Enhanced Surgical Research Support at Millin Meeting

Professor Michael Kerin, president of the Royal College of Surgeons in Ireland (RCSI), has called for increased support for surgeons to strengthen the nation's surgical research capacity. His remarks preceded the annual Millin Meeting, a gathering of leading healthcare experts focused on integrating innovation and clinical trials into everyday surgical practice.

Toddler Diagnosed With Leukemia After Symptoms Dismissed as Winter Illness

Manraj Singh Hans, now seven, was diagnosed with acute lymphoblastic leukemia in February 2023 after a prolonged period during which his early symptoms were repeatedly misdiagnosed as common infections. His parents, Narinder Singh and Parm Hans, initially dismissed signs of illness as winter fatigue before blood in the child’s diaper prompted urgent medical intervention.

American Airlines passenger falls ill and vomits on three travellers

A passenger on board an American Airlines reportedly experienced a medical episode mid-flight A morning flight from Philadelphia to Miami was thrown into disarray after a passenger reportedly vomited over three other travellers.

iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury

Researchers at Keiō University are leveraging induced pluripotent stem (iPS) cells to accelerate drug discovery for rare neurological conditions. Director Okano Hideyuki reports that human-derived cell models have enabled the rapid identification of potential treatments for amyotrophic lateral sclerosis and paved the way for regenerative therapies targeting spinal cord injuries.

Change text size: